Neuropeptide Y feeding receptors: Are multiple subtypes involved?

Trends in Pharmacological Sciences

Volumn 20, Issue 2, 1999, Pages 43-46

  Inui, Akio ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y1 RECEPTOR;

APPETITE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0033083323     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(99)01303-6     Document Type: Short Survey

References (47)

1. Larhammar D. Regul. Pept. 62:1996;1-11.
2. Grundemar, L. (1997) in Neuropeptide Y and Drug Development (Grundemar, L. and Bloom, S. R., eds), pp. 1-14, Academic Press.
3. Stanley, B. G. (1993) in The Biology of Neuropeptide Y and Related Peptides (Colmers, W. F. and Wahlestedt, C., eds), pp. 457-509, Humana Press.
4. Woods S.C.et al. Science. 28:1998;1378-1383.
5. Leibowitz S.F. Obes. Res. 3:1995;575S-589S.
6. Turton, M. D., O'Shea, D. and Bloom, S. R. (1997) in Neuropeptide Y and Drug Development (Grundemar, L. and Bloom, S. R., eds), pp. 15-39, Academic Press.
7. Kalra S.P. Neuron. 19:1997;227-230.
8. Heinrichs S.C., Menzaghi F., Koob G.F. Vitam. Horm. 54:1998;51-66.
9. Michel M.C.et al. Pharmacol. Rev. 50:1998;143-150.
10. Blomqvist A.G., Herzog H. Trends Neurosci. 20:1997;294-298.
11. Gehlert D.R. Proc. Soc. Exp. Biol. Med. 218:1998;7-22.
12. Dumont, Y., Jacques, D., St-Pierre, J-A. and Quirion, R. (1997) in Neuropeptide Y and Drug Development (Grundemar, L. and Bloom, S.R., eds), pp. 57-86, Academic Press.
13. O'Shea D.et al. Endocrinology. 138:1997;196-202.
14. Wahlestedt C., Merlo Pich E., Koob G.F., Yee F., Heilig M. Science. 259:1993;528-531.
15. Kanatani A.et al. Endocrinology. 137:1996;3177-3182.
16. Doods H.N.et al. Regul. Pept. 71:1997;212.
17. Hipskind P.A.et al. J. Med. Chem. 40:1997;3712-3714.
18. Ishihara A.et al. Am. J. Physiol. 274:1998;R1500.
19. Parker E.M.et al. Eur. J. Pharmacol. 349:1998;97-105.
20. Kanatani T.et al. Regul. Pept. 75-76:1998;409-415.
21. Lopez-Valpuesta F.J.et al. Proc. R. Soc. London B. Biol. Sci. 263:1996;881-886.
22. Caberlotto L.et al. Neuroscience. 96:1998;827-845.
23. Gerald C.et al. Nature. 382:1996;168-171.
24. Schaffhauser A.O.et al. Diabetes. 46:1997;1792-1798.
25. Hofbauer K.G.et al. Regul. Pept. 71:1997;211.
26. Criscione L.et al. Int. J. Obesity. 22( 3):1998;S16.
27. Xin X.G., Huang X.F. NeuroReport. 9:1998;737-741.
28. Small C.J.et al. Proc. Natl. Acad. Sci. U. S. A. 94:1997;11686-11691.
29. Dumont Y., Fournier A., Quirion R. J. Neurosci. 18:1998;5565-5574.
30. Strader C.D., Hwa J.J., Van Heek M., Parker E.M. Drug Discovery Today. 3:1998;250-256.
31. Campfield L.A., Smith F.J., Burn P. Science. 280:1998;1383-1387.
32. Marsh D.J.et al. Nat. Med. 4:1998;718-721.
33. Pedrazzini T.et al. Nat. Med. 4:1998;722-726.
34. Woldbye D.P.W., Larson P.J. Nat. Med. 4:1998;671-672.
35. Simmons R.M.A., Li D.L., Iyengar S. Soc. Neurosci. Abstr. 23:1997;1766.
36. Itoh, E., Fujimiya, M. and Inui, A. Biol. Psychiatry (in press).
37. Itoh E., Fujimiya M., Inui A. Regul. Pept. 75-76:1998;373-376.
38. Broberger C.et al. Neuroendocrinology. 66:1997;393-408.
39. Inui A. Trends. Neurosci. 22:1999;62-67.
40. Kask A.et al. Biochem. Biophys. Res. Commun. 248:1998;245-249.
41. Kalra P.S.et al. J. Neuroendocrinol. 10:1998;43-49.
42. Kalra P.S.et al. Regul. Pept. 72:1998;121-130.
43. Guan X-M., Yu H., Van der Ploeg L.H.T. Mol. Brain Res. 59:1998;273-279.
44. Leibowitz S.F., Alexander J.T. Peptides. 12:1991;1251-1260.
45. Naveilhan P.et al. Neuroscience. 87:1998;289-302.
46. Zukowska-Grojec Z. DN&P. 10:1997;587-595.
47. Burkhoff A.M., Linemeyer D.L., Salon J.A. Mol. Brain. Res. 53:1998;311-316.